Dillon Harrison 4
4 · SOLAZYME INC · Filed Aug 15, 2012
Insider Transaction Report
Form 4
SOLAZYME INCSZYM
Dillon Harrison
DirectorCTO and President
Transactions
- Sale
Common Stock
2012-08-15$13.13/sh−9,500$124,697→ 2,035,384 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.07 to $13.21, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.